91 related articles for article (PubMed ID: 8671791)
41. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
42. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
Rowshani AT; Scholten EM; Bemelman F; Eikmans M; Idu M; Roos-van Groningen MC; Surachno JS; Mallat MJ; Paul LC; de Fijter JW; Bajema IM; ten Berge I; Florquin S
J Am Soc Nephrol; 2006 Jan; 17(1):305-12. PubMed ID: 16306168
[TBL] [Abstract][Full Text] [Related]
43. Do cyclosporin profiles provide useful information in the management of renal transplant recipients?
Bowles MJ; Waters JB; Lechler RI; Williams G
Nephrol Dial Transplant; 1996 Aug; 11(8):1597-602. PubMed ID: 8856218
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
[TBL] [Abstract][Full Text] [Related]
45. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
46. Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy.
Tang SC; Chan KW; Tang CS; Lam MF; Leung CY; Tse KC; Li CS; Ho YW; Tong MK; Lai KN; Chan TM;
Nephrol Dial Transplant; 2006 Nov; 21(11):3243-51. PubMed ID: 16877482
[TBL] [Abstract][Full Text] [Related]
47. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
48. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial.
Reis A; Reinhard T; Voiculescu A; Kutkuhn B; Godehardt E; Spelsberg H; Althaus C; Sundmacher R
Br J Ophthalmol; 1999 Nov; 83(11):1268-71. PubMed ID: 10535855
[TBL] [Abstract][Full Text] [Related]
49. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
[TBL] [Abstract][Full Text] [Related]
50. Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation.
Patrassi GM; Sartori MT; Livi U; Casonato A; Danesin C; Vettore S; Girolami A
Transplantation; 1997 Dec; 64(11):1610-4. PubMed ID: 9415568
[TBL] [Abstract][Full Text] [Related]
51. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus.
White M; Ross H; Haddad H; LeBlanc MH; Racine N; Pflugfelder P; Giannetti N; Davies R; Azevedo E; Isaac D; Burton J; Ferguson R; Genest J
Transplantation; 2006 Sep; 82(6):763-70. PubMed ID: 17006323
[TBL] [Abstract][Full Text] [Related]
52. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
[TBL] [Abstract][Full Text] [Related]
53. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
[TBL] [Abstract][Full Text] [Related]
54. Hyperuricaemia in cyclosporin-treated patients: GFR-related effect.
Zürcher RM; Bock HA; Thiel G
Nephrol Dial Transplant; 1996 Jan; 11(1):153-8. PubMed ID: 8649625
[TBL] [Abstract][Full Text] [Related]
55. Fibrinolysis in chronic renal failure, dialysis and renal transplantation.
Opatrný K; Zemanová P; Opatrná S; Vít L
Ann Transplant; 2002; 7(1):34-43. PubMed ID: 12221902
[TBL] [Abstract][Full Text] [Related]
56. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J; Kahan BD
Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
[TBL] [Abstract][Full Text] [Related]
57. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
[TBL] [Abstract][Full Text] [Related]
58. Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients.
Apanay DC; Neylan JF; Ragab MS; Sgoutas DS
Transplantation; 1994 Sep; 58(6):663-9. PubMed ID: 7524202
[TBL] [Abstract][Full Text] [Related]
59. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
Rathi M; Rajkumar V; Rao N; Sharma A; Kumar S; Ramachandran R; Kumar V; Kohli HS; Gupta KL; Sakhuja V
Transplant Proc; 2015 May; 47(4):1158-61. PubMed ID: 26036543
[TBL] [Abstract][Full Text] [Related]
60. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
